TMC
CDAK
Trellus Management Company’s Codiak BioSciences, Inc. Common Stock CDAK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-64,582
| Closed | -$51K | – | 69 |
|
|
2022
Q3 | $51K | Sell |
64,582
-13,945
| -18% | -$11K | 0.06% | 50 |
|
|
2022
Q2 | $226K | Sell |
78,527
-5,506
| -7% | -$15.8K | 0.28% | 43 |
|
|
2022
Q1 | $527K | Hold |
84,033
| – | – | 0.31% | 31 |
|
|
2021
Q4 | $936K | Buy |
84,033
+21,063
| +33% | +$235K | 0.62% | 22 |
|
|
2021
Q3 | $1.03M | Buy |
62,970
+25,170
| +67% | +$411K | 0.75% | 33 |
|
|
2021
Q2 | $700K | Sell |
37,800
-7,200
| -16% | -$133K | 0.48% | 40 |
|
|
2021
Q1 | $679K | Buy |
+45,000
| New | +$679K | 0.35% | 35 |
|